Taken together, these results suggest that MMC not only inhibits tumour proliferation but also suppresses the activation of NLRP3 pathways and decreases the expression of inflammatory factors to prevent fibroblast proliferation and angiogenesis, thereby reducing the recurrence rate of pterygium. This evidence concerns the gene NLRP3 and pterygium.